Schedule 13G ownership disclosure

Acumen Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 00509G209

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,109,670
Percent of class
7.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000834237-22-007227
Form type
SC 13G
Filer
Acumen Pharmaceuticals, Inc.
CIK
CIK 1576885
Filed
Feb 04, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub